Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Treasury Shares (2019 - 2025)

Pulmonx has reported Treasury Shares over the past 7 years, most recently at $1.4 million for Q4 2025.

  • Quarterly Treasury Shares fell 48.97% to $1.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2025, down 48.97% year-over-year, with the annual reading at $1.4 million for FY2025, 48.97% down from the prior year.
  • Treasury Shares was $1.4 million for Q4 2025 at Pulmonx, up from $326848.0 in the prior quarter.
  • Over five years, Treasury Shares peaked at $4.1 million in Q2 2025 and troughed at $12945.0 in Q1 2021.
  • The 5-year median for Treasury Shares is $998473.0 (2022), against an average of $1.4 million.
  • Year-over-year, Treasury Shares plummeted 92.39% in 2024 and then surged 513.05% in 2025.
  • A 5-year view of Treasury Shares shows it stood at $442428.0 in 2021, then soared by 125.68% to $998473.0 in 2022, then soared by 124.83% to $2.2 million in 2023, then grew by 21.55% to $2.7 million in 2024, then plummeted by 48.97% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Treasury Shares are $1.4 million (Q4 2025), $326848.0 (Q3 2025), and $4.1 million (Q2 2025).